Inflammation and immunomodulatory therapies influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis

By sjmartinez • July 31, 2023

Karpouzas GA, Papotti B, Ormseth SR, Palumbo M, Hernandez E, Adorni MP, Zimetti F, Budoff MJ, Ronda N. Inflammation and immunomodulatory therapies influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis. J Transl Autoimmun. 2023 Jul 18;7:100209. doi: 10.1016/j.jtauto.2023.100209. PMID: 37520890; PMCID: PMC10371792.

Tags: ABCA1, Cardiology/Epi, Cardiovascular events, Cholesterol efflux capacity, Coronary Atherosclerosis, Corticosteroids, Harbor UCLA, Publications, Rheumatoid arthritis, Rheumatology

3-Year Outcomes of Mitral Valve-in-Valve Therapy Using Balloon-Expandable Transcatheter Valves in the United States

Eleid MF, Krishnaswamy A, Kapadia S, Yadav P, Rajagopal V, Makkar R, Stinis C, Chetcuti S, Morse A, Frisoli T, Frangieh AH, Abbas AE, Whisenant[...]

The Association of Arsenic Exposure and Metabolism Biomarkers with Subclinical Measures of Liver Disease: a cross-sectional investigation in the Multi-Ethnic Study of Atherosclerosis

Wu HC, Glabonjat RA, Schilling K, Anderson WA, Gao S, Relloso AD, LoIacono N, Slowly M, Nigra AE, Sanchez T, Sobel MH, Galvez-Fernandez M, Budoff[...]

Clinical and socioeconomic factors associated with recurrent atrial fibrillation after catheter ablation or antiarrhythmic drug therapy

An J, Bansal N, Zheng C, Lee MS, Wei R, Harrison TN, Fan D, Garcia E, Lidgard B, Zelnick LR, Singer DE, Go AS. Clinical[...]